Client Success Stories

Close-up of gloved hands drawing liquid from a vaccine vial with a dropper, glowing particles rising from the vial.

From Animal Models to Clinical Trials: Accelerating IND Strategy for a Solo-Founder Pharma Company

A solo-founder U.S. pharma company had decades of research and animal model data but needed a clear path to clinical development. Facet provided strategic IND guidance to help translate promising preclinical results into investigator-initiated trials across multiple disease states.

Person in a lab coat holds a tablet from which glowing interconnected molecular structures emerge.

Streamlining PET Radiopharmaceutical Development for a European Diagnostics Company

A European medical imaging company developing a novel PET radiopharmaceutical had accumulated ex-US data from over 800 patients but lacked a clear U.S. regulatory strategy. Facet stepped in to streamline development planning and reduce time and cost to approval.

Scientist wearing a lab coat and gloves examines a holographic brain scan with digital data overlays.

The Journey from Phase 3 to 505(b)(2) Submission: Closing Biometrics Gaps for a Small Pharma Team

A small U.S. pharma team was 12 months from a 505(b)(2) submission with critical biometrics gaps and no internal resources to fill them. Facet embedded expert support to close those gaps and keep the program on track.

Awards & Recognition

great place to work certified badge for may 2023 to may 2024 USAtop regulatory services provider 2023 award awarded to facet life sciences by life sciences review.great place to work certified badge for april 2024 to april 2025 USAtop regulatory services provider 2024 award awarded to facet life sciences by life sciences reviewtop regulatory services provider 2025 award awarded to facet life sciences by life sciences review